Walleye Trading
CYTK icon

Walleye Trading’s Cytokinetics CYTK Stock Holding History

Walleye Trading’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Buy
44,100
+16,000
+57% +$1.02M ﹤0.01% 1463
2025
Q4 		$1.79M Sell
28,100
-3,600
-11% -$224K ﹤0.01% 1986
2025
Q3 		$1.74M Sell
31,700
-56,500
-64% -$2.33M ﹤0.01% 1903
2025
Q2 		$2.91M Buy
88,200
+87,300
+9,700% +$3.04M 0.01% 1511
2025
Q1 		$36.2K Buy
+900
New +$41.4K ﹤0.01% 3695
2024
Q2 		– Sell
-19,600
Closed -$1.37M – 4397
2024
Q1 		$1.37M Sell
19,600
-23,300
-54% -$1.8M ﹤0.01% 1990
2023
Q4 		$3.58M Buy
42,900
+2,900
+7% +$105K 0.01% 1467
2023
Q3 		$1.18M Buy
40,000
+1,800
+5% +$59.9K ﹤0.01% 2240
2023
Q2 		$1.25M Buy
+38,200
New +$1.41M ﹤0.01% 1989
2023
Q1 		– Sell
-16,400
Closed -$751K – 4923
2022
Q4 		$751K Buy
16,400
+11,900
+264% +$512K ﹤0.01% 2470
2022
Q3 		$218K Buy
4,500
+2,000
+80% +$96.3K ﹤0.01% 3601
2022
Q2 		$98K Buy
+2,500
New +$101K ﹤0.01% 4119
2022
Q1 		– Sell
-700
Closed -$32K – 5424
2021
Q4 		$32K Sell
700
-4,800
-87% -$185K ﹤0.01% 4801
2021
Q3 		$197K Buy
+5,500
New +$162K ﹤0.01% 3862

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Walleye Trading's CYTK Position: Q1 2026 in Review

Walleye Trading sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 16,658 shares — an estimated $1.06M sold.

Walleye Trading first reported a position in CYTK in Q3 2015 and held it in 11 quarters. The position peaked at $3.45M in Q4 2023. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Walleye Trading reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 16,658 Cytokinetics shares in Q1 2026, an estimated $1.06M.
  • Walleye Trading first reported a position in Cytokinetics in Q3 2015 and held it in 11 quarters.
  • Walleye Trading's Cytokinetics position peaked at $3.45M in Q4 2023.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.